Columbus Circle Investors’s Pacira BioSciences PCRX Stock Holding History

Columbus Circle Investors’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-764,649	Closed	-$40.5M	–	283
2016 Q1	$40.5M	Buy	764,649 +25,933	+4%	+$1.52M	0.36%	70
2015 Q4	$56.7M	Buy	+738,716	New	+$41.8M	0.46%	61
2015 Q1	–	Sell	-187,902	Closed	-$16.7M	–	318
2014 Q4	$16.7M	Sell	187,902 -429,084	-70%	-$40.6M	0.12%	157
2014 Q3	$59.8M	Sell	616,986 -163,149	-21%	-$15.9M	0.43%	66
2014 Q2	$71.7M	Buy	780,135 +99,318	+15%	+$7.56M	0.49%	63
2014 Q1	$47.6M	Buy	680,817 +311,727	+84%	+$21.2M	0.32%	90
2013 Q4	$21.2M	Buy	369,090 +5,877	+2%	+$309K	0.15%	152
2013 Q3	$17.5M	Buy	+363,213	New	+$13.2M	0.12%	185

Other funds holding PCRX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

DCM

Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Columbus Circle Investors's PCRX Position: Q2 2016 in Review

Columbus Circle Investors sold out of Pacira BioSciences (PCRX) in Q2 2016, closing a stake of 764,649 shares — an estimated $40.5M sold.

Columbus Circle Investors first reported a position in PCRX in Q3 2013 and held it in 8 quarters. The position peaked at $71.7M in Q2 2014. 183 funds tracked by Wall St. Rank hold PCRX as of Q2 2016.

Columbus Circle Investors reported no remaining Pacira BioSciences position as of Q2 2016 after selling out during the quarter.
Columbus Circle Investors sold 764,649 Pacira BioSciences shares in Q2 2016, an estimated $40.5M.
Columbus Circle Investors first reported a position in Pacira BioSciences in Q3 2013 and held it in 8 quarters.
Columbus Circle Investors's Pacira BioSciences position peaked at $71.7M in Q2 2014.
183 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2016.

Based on Columbus Circle Investors's 13F filing for Q2 2016, filed 2 Aug 2016.